1hff
From Proteopedia
| Line 7: | Line 7: | ||
|ACTIVITY= | |ACTIVITY= | ||
|GENE= | |GENE= | ||
| + | |DOMAIN= | ||
| + | |RELATEDENTRY= | ||
| + | |RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1hff FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1hff OCA], [http://www.ebi.ac.uk/pdbsum/1hff PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=1hff RCSB]</span> | ||
}} | }} | ||
| Line 16: | Line 19: | ||
==About this Structure== | ==About this Structure== | ||
| - | 1HFF is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/ | + | 1HFF is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Human_herpesvirus_8 Human herpesvirus 8]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1HFF OCA]. |
==Reference== | ==Reference== | ||
Structure/function of human herpesvirus-8 MIP-II (1-71) and the antagonist N-terminal segment (1-10)., Crump MP, Elisseeva E, Gong J, Clark-Lewis I, Sykes BD, FEBS Lett. 2001 Feb 2;489(2-3):171-5. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/11165244 11165244] | Structure/function of human herpesvirus-8 MIP-II (1-71) and the antagonist N-terminal segment (1-10)., Crump MP, Elisseeva E, Gong J, Clark-Lewis I, Sykes BD, FEBS Lett. 2001 Feb 2;489(2-3):171-5. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/11165244 11165244] | ||
| - | [[Category: Human herpesvirus | + | [[Category: Human herpesvirus 8]] |
[[Category: Single protein]] | [[Category: Single protein]] | ||
[[Category: Clark-Lewis, I.]] | [[Category: Clark-Lewis, I.]] | ||
| Line 32: | Line 35: | ||
[[Category: vmip-ii]] | [[Category: vmip-ii]] | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Mar 30 21:04:01 2008'' |
Revision as of 18:04, 30 March 2008
| |||||||
| Resources: | FirstGlance, OCA, PDBsum, RCSB | ||||||
| Coordinates: | save as pdb, mmCIF, xml | ||||||
NMR SOLUTION STRUCTURES OF THE VMIP-II 1-10 PEPTIDE FROM KAPOSI'S SARCOMA-ASSOCIATED HERPESVIRUS.
Overview
Kaposi's sarcoma-associated herpesvirus encodes a chemokine called vMIP-II that has been shown to be a broad range human chemokine receptor antagonist. Two N-terminal peptides, vMIP-II(1-10) and vMIP-II(1-11)dimer (dimerised through Cys11) were synthesised. Both peptides are shown to bind the CXC chemokine receptor 4 (CXCR4). vMIP-II(1-10) was 1400-fold less potent than the native protein whilst the vMIP-II(1-11)dimer was only 180-fold less potent. In addition, both peptides are CXCR4 antagonists. Through analysis of non-standard, long mixing time two-dimensional nuclear Overhauser enhancement spectroscopy experiments, 13C relaxation data and amide chemical shift temperature gradients for the N-terminus of vMIP-II, we show that this region populates a turn-like structure over residues 5-8, both in the presence and absence of the full protein scaffold. This major conformation is likely to be in fast exchange with other conformational states but it has not previously been detected in monomeric chemokine structures. This and other studies [Elisseeva et al. (2000) J. Biol. Chem. 275, 26799-26805] suggest that there may be a link between the structuring of the short N-terminal chemokine peptides and their ability to bind their receptor.
About this Structure
1HFF is a Single protein structure of sequence from Human herpesvirus 8. Full crystallographic information is available from OCA.
Reference
Structure/function of human herpesvirus-8 MIP-II (1-71) and the antagonist N-terminal segment (1-10)., Crump MP, Elisseeva E, Gong J, Clark-Lewis I, Sykes BD, FEBS Lett. 2001 Feb 2;489(2-3):171-5. PMID:11165244
Page seeded by OCA on Sun Mar 30 21:04:01 2008
